Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry - Final Guidance
NonrulemakingOtherFDA-2020-D-1079-0064
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jan 24, 2023
- Agency
- Food and Drug Administration (FDA)